Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism
- PMID: 20413348
- PMCID: PMC4633045
- DOI: 10.1016/S1470-2045(10)70097-8
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism
Erratum in
- Lancet Oncol. 2010 Jun;11(6):516
References
-
- International Human Genome Sequencing, C. Initial sequencing and analysis of the human genome. Nature. 2001:408.
-
- Venter JC, et al. The sequence of the human genome. Science. 2001;291(5507):1304–1351. - PubMed
-
- Dressler LG, Terry SF. How will GINA influence participation in pharmacogenomics research and clinical testing? Clin Pharmacol Ther. 2009;86(5):472–5. - PubMed
-
- Green MJ, Botkin JR. “Genetic exceptionalism” in medicine: clarifying the differences between genetic and nongenetic tests. Ann Intern Med. 2003;138(7):571–5. - PubMed
-
- Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004;429(6990):464–468. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical